Legislation & Regulation

AMCP comments on biological product substitutions.

On February 1, 2017, CMS released its 2018 Draft Call Letter. Overall, the Draft Call Letter does not contain any major changes that are of serious concern to managed care pharmacy. However, there are several provisions worth noting, such as changes to Star Ratings and efforts to reduce opioid overutilization.

AMCP CEO Blog: Who says Congress can’t get anything done…and with bipartisan support to boot? With impressive speed and purpose, the House and Senate overwhelmingly passed the 21st Century Cures Act in the waning days of the 114th Congress.

Press Releases: Academy of Managed Care Pharmacy (AMCP) CEO Susan A. Cantrell, RPh, CAE, issued the following statement on President Obama’s signing today of the 21st Century Cures Act.

Press Release: A Briefing for Congressional Staff who focus on healthcare, and anyone interested in pharmaceutical pricing, Sponsored by the Academy of Managed Care Pharmacy

Press Release: The Academy of Managed Care Pharmacy today kicks off AMCP Nexus 2016 with a wide variety of educational sessions and policy discussions covering such hot topics as managing the specialty drug spend, treating opioid abuse and communicating off-label health care economic information.

Press Release: The Academy of Managed Care Pharmacy (AMCP) commends the Senate for its overwhelming 92-to-2 passage of S. 524, the Comprehensive Addiction and Recovery Act (CARA).